Ebola treatment trial: two drugs identified as more effective
Two out of the four drugs tested in a multi-drug randomised control trial have been found more effective in treating Ebola, the World Health Organization announced on Monday. The Data and Safety Monitoring Board, an independent body that has been reviewing interim safety and efficacy data, has therefore recommended that the study be stopped and that all future patients be randomized to receive either REGN-EB3 or mAb114, in what is being considered an extension phase of the study.
Staying healthy during Pride season: practice safer sex and check vaccination status
Dutch health authorities have recently reported an increase of hepatitis A infections particularly affecting men who have sex with men. With the on-going Pride events across Europe, ECDC stresses the importance of ensuring hepatitis A vaccination, (advice for) safer sex and personal hygiene practices including washing hands and genital areas before and after sex to avoid infection.
Travellers who recently received rabies post-exposure prophylaxis in Philippines advised to contact health services
The recommendation from ECDC follows reports of falsified rabies vaccines and anti-rabies serum circulating in the Philippines and is aimed at travellers who have received the vaccine or serum after possible exposure to rabies.
Targeted testing for viral hepatitis: Europe’s persistent public health challenge
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.
Ebola outbreak in the Democratic Republic of the Congo: ECDC updates assessment for Europe
After the Ebola virus disease outbreak was declared a Public Health Emergency of International Concern on 17 July 2019, ECDC updated its risk assessment for the EU/EEA on the on-going outbreak: the overall risk of introduction and further spread of the Ebola virus within the EU/EEA remains very low.
Call for ECDC Fellowship Programme (EPIET & EUPHEM) cohort 2020
The call for applications for the EU-track cohort 2020 of the ECDC Fellowship Programme is now open. Interested candidates can apply to become a fellow in one of the two paths offered by the Programme: EPIET field epidemiology and EUPHEM public health microbiology. Deadline for application is 10 September 2019, at 08.00 CEST.
Syphilis notifications in the EU/EEA up by 70% since 2010
The number of syphilis cases has been consistently going up across Europe since 2010, mostly affecting men who have sex with men living in urban areas. In 2017, notification rates reached an all-time high in the EU/EEA countries with more than 33 000 reported cases. An in-depth ECDC study published today describes the factors behind this increase and outlines the evidence-based options for public health control of syphilis, including case finding and management as well as educational activities.
Chronic hepatitis B infections on the rise since 2008
In 2017, the majority (58%) of the almost 27 000 newly reported hepatitis B cases in the European Union and European Economic Area were classified as chronic infections. This follows a consistent upward trend in reported chronic hepatitis B cases since 2008.
Epidemiological update: Ebola virus disease outbreak in North Kivu and Ituri Provinces, Democratic Republic of the Congo
As of 12 June, three imported Ebola virus cases and two deaths in Kasese District in Uganda have been confirmed by the Ugandan Ministry of Health. These are the first cases to be reported outside the Democratic Republic of the Congo since the beginning of the outbreak in August 2018.